2011 - EpiVax, Inc. - Informatics and Immunology

A fibronectin scaffold approach to bispecific inhibitors of epidermal growth factor receptor and insulin-like growth factor-I receptor

by epivax3 | Oct 22, 2016

A fibronectin scaffold approach to bispecific inhibitors of epidermal growth factor receptor and insulin-like growth factor-I receptor. Adnexus MAbs. 2011 [ISPRI prediction of immunogenicity]

VennVax, a DNA-prime, peptide-boost multi-T-cell epitope poxvirus vaccine, induces protective immunity against vaccinia infection by T cell response alone

by epivax3 | Oct 22, 2016

Vaccine. 2011. Jan 10;29(3):501-11. Epub 2010 Nov 4.

HelicoVax: Epitope-based therapeutic H. pylori vaccination in a mouse model of gastric cancer

by epivax3 | Oct 22, 2016

Vaccine. 2011. Mar 3;29(11):2085-91

Coupling sensitive in vitro and in silico techniques to assess cross-reactive CD4+ T cells against the swine-origin H1N1 influenza virus

by epivax3 | Oct 22, 2016

Vaccine 2011: Feb 21. [Epub ahead of print]

An Integrated Genomic and Immunoinformatic Approach to H. pylori Vaccine Design. 2011

by epivax3 | Oct 22, 2016

Immunome Research. Vol 7, No 2 (2011). https://immunome-research.net/journal/index.php/immunome.

A fibronectin scaffold approach to bispecific inhibitors of epidermal growth factor receptor and insulin-like growth factor-I receptor

VennVax, a DNA-prime, peptide-boost multi-T-cell epitope poxvirus vaccine, induces protective immunity against vaccinia infection by T cell response alone

HelicoVax: Epitope-based therapeutic H. pylori vaccination in a mouse model of gastric cancer

Coupling sensitive in vitro and in silico techniques to assess cross-reactive CD4+ T cells against the swine-origin H1N1 influenza virus

An Integrated Genomic and Immunoinformatic Approach to H. pylori Vaccine Design. 2011

Recent Posts

Categories